Poisoned in the Womb: When Medicine's Mistakes Echo Through Generations - Jill Escher (#19)
26 June 2025
With Jill Escher
youth-gender-medicine
The dramatic rise in autism and gender dysphoria among the young may share a biological origin in prenatal exposure to synthetic hormones — and medicine is not asking the question. Guest Jill Escher, whose own family history drew her into this research, exposes a pattern of institutional evasion stretching from the DES scandal of the mid-twentieth century to drugs still being prescribed to pregnant women as recently as 2023.
Jill Escher is an autism advocate and president of the National Council on Severe Autism. Her path to scientific advocacy began not in a laboratory but in the daily reality of raising two profoundly autistic sons. Like many parents, she spent years searching for explanations. The answer she found was not in her children's genetics but in the medical history of her own mother's pregnancy — recorded in documents that had been sitting untouched for decades. In 1965, Jill's mother received weekly injections of synthetic steroid hormones during pregnancy. These drugs were related to DES — diethylstilbestrol, the synthetic oestrogen later found to cause cancer and reproductive harm across generations — and were prescribed at the time as routine anti-miscarriage treatments. The discovery of those records reframed not just Escher's family story but her understanding of the broader neurodevelopmental crisis now unfolding across the developed world. What makes this episode particularly relevant to questions about gender dysphoria is Escher's observation that autism and gender dysphoria are rising in tandem. Clinicians in multiple countries have documented elevated rates of autism and neurodivergence among young people presenting with gender dysphoria. What has been largely missing from that conversation is a serious upstream question: could in-utero exposure to synthetic hormones or endocrine-disrupting substances be contributing to both conditions simultaneously? Escher's framework draws on epigenetics — the way environmental exposures alter gene expression without changing the underlying DNA sequence, and how those changes can be transmitted across generations. If prenatal hormone disruption shapes neural development in ways that affect social cognition, sensory processing, and identity formation, then the simultaneous surge in autism and gender dysphoria diagnoses may share a biological root that medicine has not yet chosen to seriously investigate. The episode is equally a story about institutional behaviour. Escher traces a consistent pattern from the DES disaster — in which harms were denied and minimised for decades before being formally acknowledged — to modern anti-miscarriage medications still in use until 2023. Clinical confidence, widespread prescription, silence, and belated recognition: she argues this rhythm is repeating itself, and that the scientific courage required to interrupt it is currently absent from mainstream medicine. This matters for the gender debate because it shifts the frame. If a significant proportion of the young people now presenting with gender dysphoria have brains that were shaped before birth by pharmaceutical exposures, then the purely ideological explanation — that they are simply discovering an innate, pre-given identity — becomes radically incomplete. Escher makes the case that the surge is not only a cultural or philosophical question but a public health emergency, one that demands epidemiological honesty from institutions that have so far preferred silence.
